Poster Walkthrough Sessions at ESCMID Global 2025

We are excited to introduce Poster Walkthrough Sessions at ESCMID Global 2025! These pilot sessions offer a unique opportunity for presenters and attendees to engage in dynamic discussions around selected posters in an interactive, small group setting.

Each day, one walkthrough session will be held, featuring 10 selected posters. These posters will be chosen from abstracts scheduled for presentation on that day, ensuring a focused and relevant discussion. The sessions will be informal and engaging, guided by an expert session chair who will lead the group through the selected posters, fostering in-depth conversations with presenters.

While these walkthrough sessions will not be part of the official program, they provide an excellent platform for networking and knowledge exchange.

Date & Time: 12-14 April 13:30-14:30 CET
Location: Poster Hall D, Sector C, Raw 9, Position 19-29

Immunocompromised Hosts and Transplant ID

Chair: Maddalena Gianella (Bologna, Italy)

Poster number	Presenter	Poster title
P3635	Juhui Han	Cytomegalovirus (CMV) reactivation after chimeric antigen receptor (CAR) T-cell therapy or bispecific antibodies treatment for hematologic malignancies
P3614	Gemma Reynolds	Longitudinal cytokine expression in CAR-T-treated aggressive-lymphoma patients
P0128	Amy Spallone	Outcomes of respiratory syncytial virus infections among cancer patients during the two recent respiratory viral seasons, 2022-2024
P3599	Fabián Herrera	Isavuconazole for invasive fungal infections in patients with haematologic malignancies and haematopoietic stem cell transplantation: data from the first multicentre Latin American study
P3628	Pierre-Yves Bochud	Epidemiology, risk factors and outcome of neutropaenic enterocolitis in onco-heamatological patients according to chemotherapy regimen
P3566	Laura N. Walti	Epithelial lining fluid (ELF) concentrations of beta-lactam agents in the lung allograft
P0402	Maria Dioverti	Protracted COVID-19 in immunocompromised hosts: a multicentre retrospective cohort study
P0437	Berta Pernas-Souto	Persistent SARS-CoV-2 infection among immunosuppressed patients: characterisation of subpopulations of lymphocytes
P3577	Alice Mulè	Impact of pre-transplant infection and multi-drug resistant (MDR) bacteria colonisation on in-hospital post-transplant survival in subjects with pre-transplant liver failure
P2776	Denise D'elia	Long-term survival of patients undergoing myelosuppressive therapy for acute leukaemia

Paediatric ID

Chair: Julie Toubiana (Paris, France)

Poster number	Presenter	Poster title
P0960	Juan Pablo Rodriguez-Ruiz	The gastrointestinal resistome and microbiota of children hospitalised with severe pneumonia in sub-Saharan Africa in the PediCAP trial
P1111	Cong Hieu Truong	Hospital-based surveillance of paediatric pneumococcal meningitis in southern Vietnam: clinical features and antibiotic resistance patterns (2012-2023)
P3689	Jiahui Li	Invasive pneumococcal disease and impact of 7- and 13-valent pneumococcal conjugate vaccines in Singapore children over 24 years
P2466	Antonio Arrieta	Determining the appropriateness of standard cefepime dosing in septic paediatric cancer patients: a pilot study
P0967	Anna Jones	Diagnostic stewardship for paediatric diarrhoea: a qualitative study of parent and provider perspectives
P0577	Michael Prodanuk	Host blood biomarkers for the diagnosis of childhood tuberculosis: a systematic review and meta-analysis
P0807	Marie-Liesse Etienne	Carbapenem tolerance in Enterobacter bugandensis in neonatal sepsis
P0942	Andrea Streng	Comparison of Streptococcus pneumoniae serotypes between children with paediatric parapneumonic pleural effusions/empyema and other invasive pneumococcal diseases: results from two nationwide surveillance systems, Germany, 2010/11-2023/24
P3817	Paul Rahden	Results of a randomised feasibility study of an intestinal adsorbent in acute diarrhoea in children in the Gambia
P2449	Marc Scheetz	Lessons from a large multi-national database of children: standard paediatric dosing for vancomycin results in unacceptable exposure variability

Paediatric ID

Chair: Christina Obiero (Kilifi, Kenia)

Poster number	Presenter	Poster title
P1908	Emily Gauruhn	Wider health system strengthening would be required to optimise the impact of new AWaRe antibiotics in low- and middle-income countries across sub-Saharan Africa
P1339	Jill Hopkins	ACORN2: prospective clinically oriented antimicrobial resistance surveillance data from 19 hospitals across Africa and Asia
P1412	Laura Czekster Antochevis	In vitro susceptibility to sulbactam/durlobactam of carbapenem-resistant Acinetobacter baumannii isolated from bloodstream infections: a multicentre study in Brazil
P1541	Hassan Alhawaj	Evaluation of direct blood culture antimicrobial susceptibility testing in routine diagnostic settings
P2297	Rogier van Doorn	Feasibility of microbiology interventions for surveillance of antimicrobial resistance in district-level hospitals in Vietnam
P1916	Jill Hopkins	Bacterial culture practices and views on antimicrobial resistance among hospital physicians in Africa and Asia: ACORN2 KAP survey
P1544	Oluwasegun Daramola	Comparative analysis using linear regression models to identify predictors of AMR in Africa
P1958	Rahul Garg	Contamination of CSF culture: serious risk to patient safety
P1929	Miriam Nantamu	It is not the lack of access but the lack of money that affects patients’ ability to treat uncomplicated UTIs in the community in Uganda
P1911	Anna Karin Sjöblom	From people to leaders: bridging communities and policy for global AMR mitigation

Poster Walkthrough Sessions at ESCMID Global 2025

Immunocompromised Hosts and Transplant ID

Poster number

Presenter

Poster title

Paediatric ID

Poster number

Presenter

Poster title

Paediatric ID

Poster number

Presenter

Poster title